NanoBio Corp-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:NanoBio Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013980
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
NanoBio Corp (NanoBio) is a biopharmaceutical company that develops vaccines. The company develops and commercializes intranasal and intramuscular vaccines for the prevention and treatment of infectious diseases. The company’s vaccines include anthrax, H5 influenza, pertussis, RSV, HIV, HSV-2, and seasonal influenza. It carries out research and development operations for the development of drugs and vaccines for dermatological conditions, infectious disease and other therapeutic indications. NanoBio also develops products based on proprietary NanoStat development platform that facilitates the development of topical anti-infective products and an array of mucosal vaccines. The company operates through its laboratory located in Michigan. NanoBio is headquartered in Ann Arbor, Michigan, the US.

NanoBio Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
NanoBio Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
NanoBio Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
NanoBio Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
NanoBio Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
NanoBio Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
NanoBio Corp, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
NanoBio Raises USD1.8 Million in Financing Round 10
NanoBio Raises US$11 Million In Series C Financing 11
Partnerships 12
NanoBio Enters into Contract with Health Protection Agency 12
Licensing Agreements 13
NanoBio Enters Into Licensing Agreement With Merck 13
NanoBio Enters Into Licensing Agreement With University Of Michigan 14
NanoBio Corp – Key Competitors 15
NanoBio Corp – Key Employees 16
NanoBio Corp – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Product News 18
07/27/2016: Nanobio to Present Intranasal Pertussis Vaccine Data at the Mucosal Immunology Course & Symposium Meeting 18
06/01/2016: NanoBio To Present Data Demonstrating Benefit Of Its Intramuscular Nanoemulsion Pandemic Influenza Vaccine 19
03/06/2017: NanoBio Receives SBIR Grant For Genital Herpes Vaccine 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
NanoBio Corp, Pharmaceuticals & Healthcare, Key Facts 2
NanoBio Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
NanoBio Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
NanoBio Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
NanoBio Corp, Deals By Therapy Area, 2011 to YTD 2017 8
NanoBio Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
NanoBio Raises USD1.8 Million in Financing Round 10
NanoBio Raises US$11 Million In Series C Financing 11
NanoBio Enters into Contract with Health Protection Agency 12
NanoBio Enters Into Licensing Agreement With Merck 13
NanoBio Enters Into Licensing Agreement With University Of Michigan 14
NanoBio Corp, Key Competitors 15
NanoBio Corp, Key Employees 16

★海外企業調査レポート[NanoBio Corp-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Dubai Electricity and Water Authority:発電所・企業SWOT分析
    Dubai Electricity and Water Authority - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informatio …
  • Fresenius SE & Co KGaA (FRE):医療機器:M&Aディール及び事業提携情報
    Summary Fresenius SE & Co KGaA (Fresenius) is a global health care group, which offers products and services for dialysis treatment. It provides various dialysis services through its own clinics and sells its products to other dialysis service providers. Its major products and services includes mach …
  • American Financial Group, Inc.:企業のM&A・事業提携・投資動向
    American Financial Group, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's American Financial Group, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Okamoto Industries, Inc.:企業の戦略・SWOT・財務情報
    Okamoto Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary Okamoto Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Sareum Holdings Plc (SAR):企業の財務・戦略的SWOT分析
    Sareum Holdings Plc (SAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • The Lubrizol Corporation:企業の戦略・SWOT・財務分析
    The Lubrizol Corporation - Strategy, SWOT and Corporate Finance Report Summary The Lubrizol Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Hanwei Energy Services Corp (HE):石油・ガス:M&Aディール及び事業提携情報
    Summary Hanwei Energy Services Corp (Hanwei Energy) is a chemical company that develops, manufactures and distributes plastic fibre reinforced piping systems. The company’s products include anhydride and amine cured frp pipes, fittings, fixtures and flanges. It offers client solutions such as pre-te …
  • Puretech Health plc (PRTC):製薬・医療:M&Aディール及び事業提携情報
    Summary Puretech Health plc (Puretech), formerly PureTech Ventures LLC, is a biopharmaceutical company that develops medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company develops a microbiome immune system drug-discovery platform and drug ca …
  • Liquor Control Board of Ontario:企業の戦略的SWOT分析
    Liquor Control Board of Ontario - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • BP Australia Group Pty Ltd:企業の戦略的SWOT分析
    BP Australia Group Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • RespireRx Pharmaceuticals Inc (RSPI):企業の財務・戦略的SWOT分析
    RespireRx Pharmaceuticals Inc (RSPI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Tokuyama Corporation (4043)-エネルギー分野:企業M&A・提携分析
    Summary Tokuyama Corporation (Tokuyama), formerly Nihon Soda Kogyo Co., Ltd., manufactures and sells chemicals, specialty products and cement. Its product portfolio includes soda ash, caustic soda, silicon products, vinyl chloride monomer/polymer, fine chemicals, film products, medical materials, me …
  • QinetiQ Group plc:戦略・SWOT・企業財務分析
    QinetiQ Group plc - Strategy, SWOT and Corporate Finance Report Summary QinetiQ Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • JX Nippon Oil & Energy Corporation-石油・ガス分野:企業M&A・提携分析
    Summary JX Nippon Oil & Energy Corporation (JXNOE) is a downstream refining company. The company refines and markets petroleum and petrochemical products. Its products include petrochemicals, lubricants, optical films, greases, fluids, engine oils, composites, Panaferd-AX, Tow PREPREG, sheet pallet …
  • RBC Wealth Management:企業の戦略・SWOT・財務情報
    RBC Wealth Management - Strategy, SWOT and Corporate Finance Report Summary RBC Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Acorda Therapeutics Inc (ACOR):製薬・医療:M&Aディール及び事業提携情報
    Summary Acorda Therapeutics Inc (Acorda) is a biopharmaceutical company that discovers, develops, and commercializes therapies for treating patients with neurological disorders. Its portfolio encomppases marketed products for the treatment of multiple sclerosis (MS); and for the management of spasti …
  • Triglav Group:企業の戦略・SWOT・財務分析
    Triglav Group - Strategy, SWOT and Corporate Finance Report Summary Triglav Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • AAR Corp:企業の戦略・SWOT・財務情報
    AAR Corp - Strategy, SWOT and Corporate Finance Report Summary AAR Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Assam Company India Ltd (ASSAMCO):企業の財務・戦略的SWOT分析
    Assam Company India Ltd (ASSAMCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Sihuan Pharmaceutical Holdings Group Ltd (460):企業の財務・戦略的SWOT分析
    Summary Sihuan Pharmaceutical Holdings Group Ltd (Sihuan Pharmaceutical) is a pharmaceutical company that develops, manufactures and markets prescription drugs. The company offers products in the therapeutic areas of cardio-cerebral vascular system, central nervous system, metabolism, oncology and a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆